Literatuur – 2

Boeken

Slaapproblemen?
Auteurs: Marcel Smits en Wiebe Braam
Uitgever: Poiesz Uitgevers, Serie Spreekuur Thuis
ISBN 9789066112292
Momenteel alleen tweedehands leverbaar (o.a. www.bol.com)

Slaapproblemen komen voor bij mensen van alle leeftijden: kinderen, jongvolwassenen, senioren en hoogbejaarden. Stoornissen in het slaap-waakritme ontstaan als de biologische klok en de leefwijze niet goed op elkaar zijn afgestemd. Als gevolg hiervan kunnen allerlei klachten op het gebied van gezondheid en dagelijks functioneren ontstaan. Vaak wordt niet onderkend dat die gezondheidsklachten worden veroorzaakt door het niet goed functioneren van de biologische klok. Daardoor worden deze klachten zelden goed behandeld. Dit boek geeft inzicht hoe de biologische klok het dagelijks functioneren beïnvloedt. Het legt uit welke, meestal miskende, klachten het gevolg kunnen zijn en hoe melatonine, licht en leefwijze de biologische klok beter kunnen afstellen.

Wetenschappelijke literatuur (vaak gratis te downloaden)

Invloed van melatonine in het lichaam
Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol. 2012 Apr 4;351(2):152-66. doi: 10.1016/j.mce.2012.01.004. Epub 2012 Jan 8 (gratis)

Melatonine algemeen
Cipolla-Neto J & do Amaral FG. Melatonin as a hormone: new physiological and clinical insights. Endocr Rev. 2018 Sept 12. doi: 10.1210/er.2018-00084. [Epub ahead of print]
Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, Fougerou C. Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr Neuropharmacol. 2017 Apr;15(3):434-443. doi: 10.2174/1570159X14666161228122115 (gratis)

Melatonine als antioxidant
Galano A, Tan DX, Reiter RJ. Melatonin: A Versatile Protector against Oxidative DNA Damage. Molecules. 2018 Feb 27;23(3). pii: E530. doi: 10.3390/molecules23030530 (gratis) 

Melatonine als slaapmiddel
Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL. ‘Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders’. Sleep Med Rev. 2017 Aug;34:10-22. doi: 10.1016/j.smrv.2016.06.005. Epub 2016 Jul 20
Braam W, van Geijlswijk I, Keijzer H, Smits MG, Didden R, Curfs LM. Loss of response to melatonin treatment is associated with slow melatonin metabolism. J Intellect Disabil Res. 2010;54(6):547–555. doi:10.1111/j.1365-2788.2010.01283.x
Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I. ‘Effects of exogenous melatonin on sleep: a meta-analysis’. Sleep Med Rev. 2005 Feb;9(1):41-50
Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S. ‘The efficacy and safety of exogenous melatonin for primary sleep disorders’. A meta-analysis. J Gen Intern Med. 2005 Dec;20(12):1151-8
Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G. ‘Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis’. BMJ. 2006 Feb 18;332(7538):385-93. Epub 2006 Feb 10
Cardinali DP. Melatonin: Clinical Perspectives in Neurodegeneration. Front Endocrinol (Lausanne). 2019 Jul 16;10:480. doi: 10.3389/fendo.2019.00480. eCollection 2019
Coogan AN & McGowan NM. A systematic review of circadian function, chronotype and chronotherapy in attention deficit hyperactivity disorder. Atten Defic Hyperact Disord. 2017 Sep;9(3):129-147. doi: 10.1007/s12402-016-0214-5. Epub 2017 Jan 7
Ettcheto M, Olloquequi J, Sánchez-López E, et al. Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer’s Disease Dementia. Front Aging Neurosci. 2020;11:344. Published 2020 Jan 8. doi:10.3389/fnagi.2019.00344
Havekes R, Heckman PRA, Wams EJ, Stasiukonyte N, Meerlo P, Eisel ULM. Alzheimer’s disease pathogenesis: The role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes. Cell Signal. 2019 Sep 16:109420. doi: 10.1016/j.cellsig.2019.109420. [Epub ahead of print]
Masi G, Fantozzi P, Villafranca A, Tacchi A, Ricci F, Ruglioni L, Inguaggiato E, Pfanner C, Cortese S. Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment. Neuropsychiatr Dis Treat. 2019 Mar 7;15:663-667. doi: 10.2147/NDT.S193891. eCollection 2019
Ozguner F, Koyu A, Cesur G. Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol Ind Health. 2005;21(1-2):21–26. doi:10.1191/0748233705th211oa
Tancredi N, Kohli N. Smoking cessation and duloxetine toxicity: A case report [published online ahead of print, 2020 Feb 21]. J Am Pharm Assoc (2003). 2020;S1544-3191(20)30007-8. doi:10.1016/j.japh.2020.01.003
Standaard slaapproblemen en slaapmiddelen Nederlands Huisartsen Genootschap 2014.

Melatonine bij fibromyalgie
Castaño MY, Garrido M, Rodríguez AB, Gómez MÁ. Melatonin Improves Mood Status and Quality of Life and Decreases Cortisol Levels in FibromyalgiaBiol Res Nurs. 2018 Nov 11:1099800418811634. doi: 10.1177/1099800418811634 [Epub ahead of print]
Hemati K, Amini Kadijani A, Sayehmiri F, Mehrzadi S, Zabihiyeganeh M, Hosseinzadeh A, Mirzaei A. Melatonin in the treatment of fibromyalgia symptoms: A systematic reviewComplement Ther Clin Pract. 2019 Nov 13;38:101072. doi: 10.1016/j.ctcp.2019.101072. [Epub ahead of print]

 

Melatonine en ADHD
Coogan AN & McGowan NM. A systematic review of circadian function, chronotype and chronotherapy in attention deficit hyperactivity disorder. Atten Defic Hyperact Disord. 2017 Sep;9(3):129-147. doi: 10.1007/s12402-016-0214-5. Epub 2017 Jan 7
McDonagh MS, Holmes R, Hsu F. Pharmacologic Treatments for Sleep Disorders in Children: A Systematic Review J Child Neurol. 2019 Jan 23:883073818821030. doi: 10.1177/0883073818821030 [Epub ahead of print]
McGowan NM, Uzoni A, Faltraco F, Thome J, Coogan AN. The impact of social jetlag and chronotype on attention, inhibition and decision making in healthy adults (published online ahead of print, 2020 Jan 14). Sleep Res. 2020;e12974. doi:10.1111/jsr.12974

Melatonine en alzheimer
Cardinali DP. Melatonin: Clinical Perspectives in NeurodegenerationFront Endocrinol (Lausanne). 2019 Jul 16;10:480. doi: 10.3389/fendo.2019.00480. eCollection 2019
Ettcheto M, Olloquequi J, Sánchez-López E, et al. Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer’s Disease DementiaFront Aging Neurosci. 2020;11:344. Published 2020 Jan 8. doi:10.3389/fnagi.2019.00344
Havekes R, Heckman PRA, Wams EJ, Stasiukonyte N, Meerlo P, Eisel ULM. Alzheimer’s disease pathogenesis: The role of disturbed sleep in attenuated brain plasticity and neurodegenerative processesCell Signal. 2019 Sep 16:109420. doi: 10.1016/j.cellsig.2019.109420. [Epub ahead of print]
Spinedi E, Cardinali DP. Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer’s Disease and MelatoninNeuroendocrinology. 2019;108(4):354-364. doi: 10.1159/000494889. Epub 2018 Oct 28

Melatonine en autisme
Wiebe Braam, Friederike Ehrhart, Anneke P.H.M. Maas, Marcel G. Smits, Leopold Curfs. Lage melatoninespiegel bij moeder vergroot risico op autisme bij haar kindTijdschrift voor Artsen voor Verstandelijk Gehandicapten 2018; 36: 98-102
Braam W, Ehrhart F, Maas APHM, Smits MG, Curfs L. Low maternal melatonin level increases autism spectrum disorder risk in childrenRes Dev Disabil. 2018 Feb 28. pii: S0891-4222(18)30042-8. doi: 10.1016/j.ridd.2018.02.017. [Epub ahead of print]
Williams Buckley A, Hirtz D, Oskoui M, et al. Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology [published online ahead of print, 2020 Feb 12]. Neurology. 2020;10.1212/WNL.0000000000009033. doi:10.1212/WNL.0000000000009033
Gagnon K & Godbout R. Melatonin and Comorbidities in Children with Autism Spectrum Disorder.Curr Dev Disord Rep. 2018;5(3):197-206. doi: 10.1007/s40474-018-0147-0. Epub 2018 Aug 9.Melatonine en borstkanker González-González A, Mediavilla MD, Sánchez-Barceló EJ. Melatonin: A Molecule for Reducing Breast Cancer RiskMolecules. 2018 Feb 6;23(2). pii: E336. doi: 10.3390/molecules23020336 (gratis)
Ghozy S, Tran L, Naveed S, Quynh TTH, Helmy Zayan A, Waqas A, Sayed AKH, Karimzadeh S, Hirayama K, Huy NT. Association of breastfeeding status with risk of autism spectrum disorder: A systematic review, dose-response analysis and meta-analysisAsian J Psychiatr. 2019 Dec 27;48:101916. doi: 10.1016/j.ajp.2019.101916. [Epub ahead of print]
Jin Y, Choi J, Won J, Hong Y. The Relationship between Autism Spectrum Disorder and Melatonin during Fetal DevelopmentMolecules. 2018 Jan 18;23(1). pii: E198. doi: 10.3390/molecules23010198 (gratis)
Lalanne S, Fougerou-Leurent C, Anderson GM, Schroder CM, Nir T, Chokron S, Delorme R, Claustrat B, Bellissant E, Kermarrec S, Franco P, Denis L, Tordjman S. Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder. Int J Mol Sci. 2021 Feb 2;22(3):1490
Manohar H, Pravallika M, Kandasamy P, Chandrasekaran V, Rajkumar RP. Role of Exclusive Breastfeeding in Conferring Protection in Children At-Risk for Autism Spectrum Disorder: Results from a Sibling Case-control Study. J Neurosci Rural Pract. 2018 Jan-Mar;9(1):132-136. doi: 10.4103/jnrp.jnrp_331_17
Rybnikova N, Portnov BA. Population-level study links short-wavelength nighttime illumination with breast cancer incidence in a major metropolitan areaChronobiol Int. 2018 May 16:1-11. doi: 10.1080/07420528.2018.1466802. [Epub ahead of print]

Melatonine en borstkanker

Gurunathan S, Qasim M, Kang MH, Kim JH. Role and Therapeutic Potential of Melatonin in Various Type of Cancers. Onco Targets Ther. 2021 Mar 18;14:2019-2052. doi: 10.2147/OTT.S298512. PMID: 33776451; PMCID: PMC7987311.

Tran QH, Than VT, Luu PL, Clarke D, Lam HN, Nguyen TT, Nguyen DT, Duy PQ, Phung D, Nguyen MN. A novel signature predicts recurrence risk and therapeutic response in breast cancer patients. Int J Cancer. 2021 Jun 1;148(11):2848-2856. doi: 10.1002/ijc.33512. Epub 2021 Feb 21. PMID: 33586202.

 

 

Follow by Email